Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
FOXO3-Mediated Metabolic Inhibition in Hepatocellular Carcin
2026-05-20
The referenced study uncovers FOXO3 as a pivotal suppressor of both glycolysis and glutaminolysis in hepatocellular carcinoma (HCC), acting via transcriptional repression of YAP. This dual metabolic targeting offers a mechanistically distinct strategy for impeding HCC growth and suggests new avenues for metabolic-based therapy.
-
Mubritinib (TAK 165) as an Inhibitor of Monkeypox Virus Repl
2026-05-20
Chiem et al. systematically screened diverse small molecules and identified Mubritinib (TAK 165) as a potent in vitro inhibitor of monkeypox virus (MPXV) replication. Their study expands the antiviral landscape by demonstrating that mitochondrial complex I inhibition, traditionally explored in cancer research, can suppress orthopoxvirus infection, suggesting new research avenues for drug repurposing.
-
AMPK Modulation Attenuates Airway Inflammation in Obesity-Re
2026-05-19
This study demonstrates that AMPK activation suppresses M1 macrophage polarization through the JAK2/STAT3 pathway, leading to reduced airway inflammation in obesity-related asthma. The findings highlight a mechanistic framework for targeting macrophage-mediated inflammation, suggesting new therapeutic avenues for refractory asthma subtypes.
-
Sodium Orthovanadate (Na3VO4): Reliable Phosphatase Inhibiti
2026-05-19
This scenario-driven guide explores how Sodium Orthovanadate (SKU A8524) delivers reproducible, high-sensitivity inhibition of phosphatases for robust phosphorylation state preservation in cell assays. Integrating protocol insights and vendor comparisons, it demystifies practical workflow challenges and provides evidence-backed recommendations for biomedical researchers, lab technicians, and postgraduates.
-
SM-102 for mRNA Delivery: Protocol Advances & Troubleshootin
2026-05-18
SM-102, a high-purity ionizable lipid, empowers robust mRNA delivery via lipid nanoparticles, driving efficiency in vaccine and therapeutic workflows. This guide translates recent machine learning-validated insights into actionable protocols and troubleshooting strategies to optimize your mRNA delivery systems.
-
CCG-1423 (SKU B4897): Precision RhoA Inhibition for Reliable
2026-05-18
This scenario-driven guide empowers biomedical researchers and lab technicians to address real-world challenges in cell viability, proliferation, and cytotoxicity workflows using CCG-1423 (SKU B4897). Evidence-based Q&A blocks illustrate how this potent RhoA inhibitor, supplied by APExBIO, enhances reproducibility and mechanistic clarity in RhoA/ROCK signaling pathway studies.
-
Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry
2026-05-17
Wang et al. (2018) provide pivotal mechanistic insight into how type III grass carp reovirus (GCRV104) invades host cells, establishing clathrin-mediated, pH-dependent endocytosis as the dominant entry pathway. Their systematic inhibitor analysis not only clarifies viral entry biology but also refines the experimental landscape for future antiviral research in aquatic virology.
-
Novel 3-DT Brassinosteroid Derivatives: Synthesis and Bioact
2026-05-16
This study presents the synthesis of new 3-dehydroteasterone derivatives with 23,24-dinorcholanic side chains and benzoate groups at C-22, evaluating their plant growth-regulating activities through rice lamina inclination and bean second-internode assays. The findings illuminate structure–activity relationships among brassinosteroid analogs, with implications for both fundamental plant biology and the design of potent plant growth regulators.
-
Heparin Sodium: Optimizing Anticoagulant Assays in Thrombosi
2026-05-15
Heparin sodium stands out as the gold-standard glycosaminoglycan anticoagulant for thrombosis research, offering reproducibility and protocol flexibility. This article translates recent mechanistic insights and workflow innovations into actionable steps for researchers, with a focus on anti-factor Xa and aPTT assays, advanced delivery, and practical troubleshooting.
-
LY294002 in PI3K Signaling: Precision Tools Beyond Oncology
2026-05-15
Explore how LY294002, a potent PI3K/Akt/mTOR signaling pathway inhibitor, enables advanced dissection of cellular signaling beyond cancer research. This article uniquely connects molecular pharmacology with practical assay design and incorporates new insights from synaptic plasticity studies.
-
Human Gastrin I: Pioneering GI Physiology and Organoid Resea
2026-05-14
This thought-leadership article explores how human Gastrin I peptide is revolutionizing gastric acid secretion pathway research within human pluripotent stem cell-derived intestinal organoid systems. By integrating recent advances in organoid modeling, mechanistic CCK2 receptor biology, and translational workflows, we deliver actionable guidance for researchers advancing gastrointestinal disorder research and drug discovery. Evidence is rigorously cited, with protocol parameters and strategic recommendations tailored for maximum experimental and clinical impact. APExBIO's Gastrin I (human) is positioned as an indispensable research tool, with competitive differentiation and future outlook contextualized against the latest literature.
-
Translating Mechanistic Insights to Oncology Screens: L1023
2026-05-14
This thought-leadership article explores how the DiscoveryProbe™ Anti-cancer Compound Library (SKU: L1023) empowers translational researchers to bridge emerging mechanistic discoveries—such as STING pathway activation—with high-throughput oncology drug discovery. By integrating evidence from recent structural and functional studies with scenario-driven workflow guidance, the piece provides a roadmap for leveraging L1023 to navigate complex signaling landscapes, maximize screening efficiency, and enable actionable biomarker discovery. The article distinguishes itself by connecting cutting-edge mechanistic biology with practical, protocol-ready strategies for the modern translational lab.
-
S Tag Peptide (SKU A6007): Technical Guidance for Protein Ta
2026-05-13
S Tag Peptide addresses persistent challenges in recombinant protein detection, purification, and solubility improvement, serving as a reliable N- or C-terminal fusion tag. It is best suited for workflows relying on anti-S-Tag antibody detection and affinity purification, but should not be chosen where ethanol solubility or long-term aqueous storage is required.
-
Minoxidil Sulphate in Vascular & Hair Growth Research: Appli
2026-05-13
Minoxidil sulphate empowers both vascular biology and hair growth research with unmatched solubility, validated purity, and robust potassium channel modulation. This article translates the latest experimental evidence into actionable protocols and troubleshooting strategies, ensuring reproducible data and high-impact insights for translational scientists.
-
E. coli Uracil-DNA Glycosylase (UDG): Technical Workflow Gui
2026-05-12
E. coli Uracil-DNA Glycosylase (UDG) is used to remove uracil residues from DNA, minimizing PCR product contamination and improving DNA amplification fidelity in research workflows. It is not suitable for RNA substrates, short oligonucleotides, or any clinical/diagnostic use. For maximum performance, follow documented storage and workflow recommendations.